# Efficacy and Safety of Two Regimens of Anti-VEGF Therapy in Chinese Patients With Polypoidal Choroidal Vasculopathy

> **NCT04380974** · PHASE4 · UNKNOWN · sponsor: **Xiaodong Sun** · enrollment: 102 (estimated)

## Conditions studied

- Polypoidal Choroidal Vasculopathy

## Interventions

- **PROCEDURE:** OCTA plus OCT guided 3+PRN regimen
- **PROCEDURE:** OCT guided 3+PRN regimen
- **DRUG:** Anti-VEGF drug

## Key facts

- **NCT ID:** NCT04380974
- **Lead sponsor:** Xiaodong Sun
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06
- **Primary completion:** 2020-10
- **Final completion:** 2022-09
- **Target enrollment:** 102 (ESTIMATED)
- **Last updated:** 2020-05-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04380974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04380974, "Efficacy and Safety of Two Regimens of Anti-VEGF Therapy in Chinese Patients With Polypoidal Choroidal Vasculopathy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04380974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*